Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nevro Reaffirms FY24 Revenue Guidance Of $435M-$445M (Est $441.038M), Sees Q2 Revenue Of $106M-$108M (Est $111.244M)

Author: Benzinga Newsdesk | May 07, 2024 05:46pm

Nevro is raising its adjusted EBITDA guidance for the full-year 2024 to a range of negative $5 million to positive $2 million from its previous guidance range of negative $14 million to negative $8 million. 

For the second quarter of 2024, the company expects worldwide revenue to be in the range of approximately $106 million to $108 million and adjusted EBITDA to be in the range of negative $3.5 million to negative $2.5 million.

Posted In: NVRO